<VariationArchive VariationID="88866" VariationName="NM_001031726.4(C19orf12):c.164_166delGGG" VariationType="Deletion" Accession="VCV000088866" Version="32" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="8" DateLastUpdated="2024-07-15" DateCreated="2019-01-13" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="94435" VariationID="88866">
      <GeneList>
        <Gene Symbol="C19orf12" FullName="chromosome 19 open reading frame 12" GeneID="83636" HGNC_ID="HGNC:25443" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="29698886" stop="29715789" display_start="29698886" display_stop="29715789" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="30189792" stop="30206695" display_start="30189792" display_stop="30206695" Strand="-" />
          </Location>
          <OMIM>614297</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001031726.4(C19orf12):c.164_166delGGG</Name>
      <CanonicalSPDI>NC_000019.10:29702971:CCCCCCC:CCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="29702972" stop="29702974" display_start="29702972" display_stop="29702974" variantLength="3" positionVCF="29702971" referenceAlleleVCF="GCCC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="30193879" stop="30193881" display_start="30193879" display_stop="30193881" variantLength="3" positionVCF="30193878" referenceAlleleVCF="GCCC" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>C19ORF12, 3-BP DEL, NT197</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031726.3" sequenceAccession="NM_001031726" sequenceVersion="3" change="c.197_199delGGG">
            <Expression>NM_001031726.3:c.197_199delGGG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031726.4" sequenceAccession="NM_001031726" sequenceVersion="4" change="c.164_166delGGG">
            <Expression>NM_001031726.4:c.164_166delGGG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.29702976_29702978del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.29702976_29702978del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.30193883_30193885del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.30193883_30193885del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031970.2" sequenceAccession="NG_031970" sequenceVersion="2" change="g.17816_17818del">
            <Expression>NG_031970.2:g.17816_17818del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031448.6" sequenceAccession="NM_031448" sequenceVersion="6" change="c.164_166delGGG" MANESelect="true">
            <Expression>NM_031448.6:c.164_166delGGG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA266201" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614297.0007" DB="OMIM" />
        <XRef Type="rs" ID="398122409" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001031726.4(C19orf12):c.164_166delGGG AND Neurodegeneration with brain iron accumulation 4" Accession="RCV000074455" Version="20">
        <ClassifiedConditionList TraitSetID="7628">
          <ClassifiedCondition DB="MedGen" ID="C3280371">Neurodegeneration with brain iron accumulation 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-08" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001031726.4(C19orf12):c.164_166delGGG AND not provided" Accession="RCV001311507" Version="30">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-01-27" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001031726.4(C19orf12):c.164_166delGGG AND Neurodegeneration with brain iron accumulation" Accession="RCV002265593" Version="9">
        <ClassifiedConditionList TraitSetID="9400">
          <ClassifiedCondition DB="MedGen" ID="C2931845">Neurodegeneration with brain iron accumulation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-29" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001031726.4(C19orf12):c.164_166delGGG AND Neurofibromatosis, type 1" Accession="RCV004562242" Version="1">
        <ClassifiedConditionList TraitSetID="96">
          <ClassifiedCondition DB="MedGen" ID="C0027831">Neurofibromatosis, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-10-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-29" NumberOfSubmissions="9" NumberOfSubmitters="8" DateCreated="2019-01-13" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22584950</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23857908</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31518459</ID>
        </Citation>
        <DescriptionHistory Dated="2022-07-17">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9400" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9539" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodegeneration with brain iron accumulation</ElementValue>
                <XRef ID="156905" DB="GeneTests" />
                <XRef ID="MONDO:0018307" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS234200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11899" />
                <XRef ID="11899" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review">
                <ID Source="PubMed">22704258</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="385" DB="Orphanet" />
              <XRef ID="C2931845" DB="MedGen" />
              <XRef ID="MONDO:0018307" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS234200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="96" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5630" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEUROFIBROMATOSIS, TYPE I, SOMATIC</ElementValue>
                <XRef Type="Allelic variant" ID="613113.0027" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0026" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neurofibromatosis, type 1</ElementValue>
                <XRef ID="Neurofibromatosis+type+1/5174" DB="Genetic Alliance" />
                <XRef ID="92824003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEUROFIBROMATOSIS, TYPE I</ElementValue>
                <XRef Type="MIM" ID="162200" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0030" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0046" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0043" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0044" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0032" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0024" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0042" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0041" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0029" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0031" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0037" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613113.0015" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peripheral type neurofibromatosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Recklinghausen's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Recklinghausen disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NF1</ElementValue>
                <XRef Type="MIM" ID="162200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7866" />
                <XRef ID="7866" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Neurofibromatosis 1 (NF1) is a multisystem disorder characterized by multiple café au lait macules, intertriginous freckling, multiple cutaneous neurofibromas, and learning disability or behavior problems. About half of people with NF1 have plexiform neurofibromas, but most are internal and not suspected clinically. Plexiform neurofibromas can cause pain, neurologic deficits, and abnormalities of involved or adjacent structures. Less common but potentially more serious manifestations include optic nerve and other central nervous system gliomas, malignant peripheral nerve sheath tumors, scoliosis, tibial dysplasia, vasculopathy, and gastrointestinal, endocrine, or pulmonary disease.</Attribute>
                <XRef ID="NBK1109" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501087" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568167" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562234" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521546" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552183" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528529" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569525" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521505" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510677" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260605" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510679" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500881" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528459" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551630" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552305" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562235" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514608" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500971" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000335545" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556388" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576339" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511188" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500970" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561868" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000333054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568134" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501088" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509686" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556576" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529068" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528533" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521399" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500115" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514981" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511186" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500972" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514913" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301288</ID>
                <ID Source="BookShelf">NBK1109</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 1995">
                <ID Source="pmc">1801355</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2007">
                <ID Source="PubMed">17636453</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111019</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2014">
                <ID Source="PubMed">24893135</ID>
              </Citation>
              <Citation Type="general" Abbrev="NANETS, 2010">
                <ID Source="PubMed">20664475</ID>
                <ID Source="pmc">3419007</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 2015">
                <ID Source="PubMed">26140447</ID>
                <ID Source="pmc">4570999</ID>
              </Citation>
              <Citation Type="general" Abbrev="NANETS, 2021">
                <ID Source="PubMed">33939658</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2020">
                <ID Source="PubMed">32602153</ID>
              </Citation>
              <XRef ID="636" DB="Orphanet" />
              <XRef ID="C0027831" DB="MedGen" />
              <XRef ID="MONDO:0018975" DB="MONDO" />
              <XRef Type="MIM" ID="162200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7628" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16586" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodegeneration with brain iron accumulation 4</ElementValue>
                <XRef ID="MONDO:0013674" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL PROTEIN-ASSOCIATED NEURODEGENERATION</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA4</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MPAN</ElementValue>
                <XRef Type="MIM" ID="614298" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12569" />
                <XRef ID="12569" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Mitochondrial membrane protein-associated neurodegeneration (MPAN) is characterized initially by gait changes followed by progressive spastic paresis, progressive dystonia (which may be limited to the hands and feet or more generalized), neuropsychiatric abnormalities (emotional lability, depression, anxiety, impulsivity, compulsions, hallucinations, perseveration, inattention, and hyperactivity), and cognitive decline. Additional early findings can include dysphagia, dysarthria, optic atrophy, axonal neuropathy, parkinsonism, and bowel/bladder incontinence. Survival is usually well into adulthood. End-stage disease is characterized by severe dementia, spasticity, dystonia, and parkinsonism.</Attribute>
                <XRef ID="NBK185329" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520058" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552041" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529414" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508834" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553399" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512825" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24575447</ID>
                <ID Source="BookShelf">NBK185329</ID>
              </Citation>
              <XRef ID="289560" DB="Orphanet" />
              <XRef ID="C3280371" DB="MedGen" />
              <XRef ID="MONDO:0013674" DB="MONDO" />
              <XRef Type="MIM" ID="614298" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="183664" SubmissionDate="2019-07-19" DateLastUpdated="2019-07-22" DateCreated="2013-11-28">
        <ClinVarSubmissionID localKey="614297.0007_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4, AUTOSOMAL RECESSIVE" title="C19ORF12, 3-BP DEL, NT197_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV000108471" DateUpdated="2019-07-22" DateCreated="2013-11-28" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs with neurodegeneration with brain iron accumulation-4 (NBIA4; 614298), Deschauer et al. (2012) identified compound heterozygous mutations in the C19ORF12 gene: a 3-bp in-frame deletion (c.197_199del), resulting in the deletion of a highly conserved residue (Gly33) in the predicted transmembrane domain, and a T11M substitution (614297.0002). The mother was heterozygous for the T11M mutation; DNA from the father was not available. The 3-bp deletion was not found in 1,000 control chromosomes and was absent from 80 HapMap individuals and the 1000 Genomes Project database. The patients were 27 and 17 years of age at the time of the report. Both had upper and lower motor neuron signs with pes cavus, winged scapula, and calf atrophy, and some difficulty walking. One had hyporeflexia with extensor plantar responses, whereas the other had hyperreflexia with clonus. Nerve studies showed reduced amplitudes with normal conduction times, consistent with axonal neuropathy. Both patients also had cognitive impairment with disinhibited and impulsive behavior; the younger sib had a history of global developmental delay since age 3 years. A third unrelated patient with a similar disorder was found to be compound heterozygous for the 3-bp deletion and an 11-bp deletion (614297.0001). Each unaffected parent was heterozygous for 1 of the mutations. This patient had onset of gait difficulties at age 9 years, distal muscle weakness, hyperreflexia, pes cavus, atrophy of the thenar muscles, learning difficulties, visual impairment due to optic atrophy, and emotional lability. Brain MRI of all 3 patients showed T2-weighted hypointensities in the global pallidus with some hypointensities also in the substantia nigra and cerebral peduncles, consistent with iron deposition. Deschauer et al. (2012) noted that the phenotype was reminiscent of juvenile-onset amyotrophic lateral sclerosis (ALS).</Attribute>
              <Citation>
                <ID Source="PubMed">22584950</ID>
              </Citation>
              <XRef DB="OMIM" ID="614298" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Landoure et al. (2013) identified a homozygous c.197_199del in a patient with NBIA4. He presented at age 4 years with speech difficulty followed by progressive spasticity and impaired walking. Other features included psychomotor slowness, weakness and atrophy of the distal extremities, and small, pale optic discs. EMG showed denervation consistent with a motor neuropathy, and brain MRI showed iron deposition in the globus pallidus. In vitro functional expression studies in COS-7 cells showed that the mutant protein had a different intracellular localization compared to wildtype, with more generalized distribution throughout the cytoplasm rather than normal localization to the mitochondria or endoplasmic reticulum.</Attribute>
              <Citation>
                <ID Source="PubMed">23857908</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19ORF12" />
          </GeneList>
          <Name>C19ORF12, 3-BP DEL, NT197</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, NT197</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614297.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3429925" SubmissionDate="2021-09-02" DateLastUpdated="2021-09-08" DateCreated="2021-07-07">
        <ClinVarSubmissionID localKey=":Chr.19_30193878_30193881_GCCC_G|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001741932" DateUpdated="2021-09-08" DateCreated="2021-07-07" Type="SCV" Version="3" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" OrgID="506382" OrganizationCategory="laboratory" OrgAbbreviation="DL-UMCG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="G" referenceAllele="GCCC" start="30193878" stop="30193881" variantLength="4" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <StudyDescription>VKGL Data-share Consensus</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB10172767</SubmissionName>
          <SubmissionName>SUB10306554</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5004578" SubmissionDate="2022-08-03" DateLastUpdated="2023-03-04" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="GDXSV:235327" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002558625" DateUpdated="2023-03-04" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 1 amino acid in a non-repeat region; Published functional studies demonstrate abnormal subcellular protein distribution (Landoure et al., 2013); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23857908, 22584950)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19ORF12" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1741743</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001031726.3:c.197_199del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_119_20220803054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4987308" SubmissionDate="2023-05-17" DateLastUpdated="2023-06-03" DateCreated="2022-07-18">
        <ClinVarSubmissionID localKey="NM_001031726.4:c.164_166delGGG|MedGen:CN043643" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002548112" DateUpdated="2023-06-03" DateCreated="2022-07-18" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22584950</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31518459</ID>
          </Citation>
          <Comment>Variant summary: C19orf12 c.164_166delGGG/p.Gly55del (legacy name: c.197_199delGGG/p.Gly66del) results in an in-frame deletion that is predicted to remove one amino acid from the transmembrane domain of the encoded protein. The variant allele was found at a frequency of 1.2e-05 in 248898 control chromosomes. c.164_166delGGG has been reported in the literature as a compound heterozygous genotype in at-least three individuals affected with Neurodegeneration With Brain Iron Accumulation (example, Deschauer_2012 cited in Dusek_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001031726.4:c.164_166delGGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN043643" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11800792</SubmissionName>
          <SubmissionName>SUB13370974</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7569575" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="30-20230924" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004045891" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001332" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001257" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001251" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0012675" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="G" referenceAllele="GCCC" start="30193878" stop="30193881" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614298" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-09-24</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9803415" SubmissionDate="2024-06-06" DateLastUpdated="2024-06-09" DateCreated="2024-06-09">
        <ClinVarSubmissionID localKey="NM_031448.6:c.164_166delGGG|OMIM:162200" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV005049558" DateUpdated="2024-06-09" DateCreated="2024-06-09" Type="SCV" Version="1" SubmitterName="Diagnostics Centre, Carl Von Ossietzky University Oldenburg" OrgID="509260" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22584950</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23857908</ID>
          </Citation>
          <Comment>The variant C19orf12:c.164_166delGGG, p.(Gly55del), which is located in the coding exon 3 of the C19orf12 gene, results from a three-base deletion at nucleotide position c.164_166. The glycine at protein position 55 is deleted. This amino acid position is located in a transmembrane domain of the protein and is evolutionarily highly conserved. The variant has been consistenly classified as Pathogenic or Likely pathogenic in seven entries in ClinVar (ClinVar ID: 88866). The variant has been described in compound heterozygosity with another pathogenic deletion (PMID: 22584950). Experimental studies showed a deleterious effect in the protein since the variant affected the proper subcellular localisation of the altered protein (PMID: 23857908). The variant is classified as rare in the overall population (allele frequency= 0.00001859 in gnomAD v4.1.0). In summary, this variant is classified as Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_031448.6:exon 3</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="398122409" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_031448.6:c.164_166delGGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="162200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14507733</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9803419" SubmissionDate="2024-06-06" DateLastUpdated="2024-06-09" DateCreated="2024-06-09">
        <ClinVarSubmissionID localKey="NM_031448.6:c.164_166delGGG|OMIM:614298" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV005049562" DateUpdated="2024-06-09" DateCreated="2024-06-09" Type="SCV" Version="1" SubmitterName="Diagnostics Centre, Carl Von Ossietzky University Oldenburg" OrgID="509260" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-23">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The variant C19orf12:c.164_166delGGG, p.(Gly55del), which is located in the coding exon 3 of the C19orf12 gene, results from a three-base deletion at nucleotide position c.164_166. The glycine at protein position 55 is deleted. This amino acid position is located in a transmembrane domain of the protein and is evolutionarily highly conserved. The variant has been consistenly classified as Pathogenic or Likely pathogenic in seven entries in ClinVar (ClinVar ID: 88866). The variant has been described in compound heterozygosity with another pathogenic deletion (PMID: 22584950). Experimental studies showed a deleterious effect in the protein since the variant affected the proper subcellular localisation of the altered protein (PMID: 23857908). The variant is classified as rare in the overall population (allele frequency= 0.00001859 in gnomAD v4.1.0). In summary, this variant is classified as Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_031448.6:exon 3</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="398122409" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_031448.6:c.164_166delGGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614298" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14507733</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2958280" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2021-03-14">
        <ClinVarSubmissionID localKey="105023|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001501702" DateUpdated="2024-07-15" DateCreated="2021-03-14" Type="SCV" Version="20" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="G" referenceAllele="GCCC" start="30193878" stop="30193881" variantLength="4" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3547446" SubmissionDate="2021-08-24" DateLastUpdated="2021-08-25" DateCreated="2021-08-25">
        <ClinVarSubmissionID localKey=":Chr.19_30193878_30193881_GCCC_G|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001807530" DateUpdated="2021-08-25" DateCreated="2021-08-25" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, Amsterdam University Medical Center" OrgID="506453" OrganizationCategory="laboratory" OrgAbbreviation="VUMC GD" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="C19orf12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="G" referenceAllele="GCCC" start="30193878" stop="30193881" variantLength="4" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10240015</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9803415" TraitType="Disease" MappingType="XRef" MappingValue="162200" MappingRef="OMIM">
        <MedGen CUI="C0027831" Name="Neurofibromatosis, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3547446" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3429925" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5004578" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569575" TraitType="Disease" MappingType="XRef" MappingValue="614298" MappingRef="OMIM">
        <MedGen CUI="C3280371" Name="Neurodegeneration with brain iron accumulation 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4987308" TraitType="Disease" MappingType="XRef" MappingValue="CN043643" MappingRef="MedGen">
        <MedGen CUI="C2931845" Name="Neurodegeneration with brain iron accumulation" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9803419" TraitType="Disease" MappingType="XRef" MappingValue="614298" MappingRef="OMIM">
        <MedGen CUI="C3280371" Name="Neurodegeneration with brain iron accumulation 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569575" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001332" MappingRef="HP">
        <MedGen CUI="C0013421" Name="Dystonic disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569575" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001251" MappingRef="HP">
        <MedGen CUI="C0007758" Name="Cerebellar ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569575" TraitType="Disease" MappingType="XRef" MappingValue="HP:0012675" MappingRef="HP">
        <MedGen CUI="C4021076" Name="Iron accumulation in brain" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2958280" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569575" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001257" MappingRef="HP">
        <MedGen CUI="C0026838" Name="Spasticity" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

